Exposure of experimental animals to biologically effective levels of chemicals, either endogenou s or exogenous , the latter of either synthetic or natural origin, elicits a response(s) that re ects the diverse ways in which the various units of organization of an organism deal with chemical perturbation. For some chemicals, an initial response constitutes an adaptive effect that maintains homeostasis. Disruption of this equilibrium at any level of organization leads to an adverse effect, or toxicity. The livers of laboratory animals and humans, like other organs, undergo programmed phases of growth and development , characterized by proliferation followed by differentiation. With organ maturity, the process of differentiation leads to the commitment of differentiated cells to constitutive functions that maintain homeostasis and to specialized functions that serve organismal needs. In the mature livers of all species, proliferation of all cell types subsides to a low level. Thus, the mature liver consists of 2 types of cells: intermediate cells, the hepatocytes , which replicate infrequentl y, but can respond to signals for replication, and replicating cells, the stem cells, endothelial, Kupffer, and stellate cells (Ito or pericytes), bile duct epithelium, and granular lymphocyte s (pit cells). Quanti able alterations or effects at the molecular level underlie alterations at the organelle level, which in turn lead to alterations at the cellular level, which can ultimately be manifested as a change in the whole organism. Alterations can be quantal (binary), either all or none, as with cell replication, cell necrosis or apoptosis, and cell differentiation, which take place at the cellular level. They can also be graded or continuous (nonbinary ), as with enzyme induction, organelle hypertrophy, and extracellular matrix elaboration, occurring either at the intra-or extra (supra) cellular level. Any quanti able change induced in the function or structure of a cell or tissue constitutes a response or effect. Each of the several types of cell in the liver responds to a given stimulus according to its localization and function. Generally, renewing cells are more vulnerable to chemical injury than intermediate cells, which are largely quiescent. Hepatic adaptive responses usually involve actions of the chemical on cellular regulatory pathways, often receptor mediated, leading to changes in gene expression and ultimately alteration of the metabolome. The response is directed toward maintaining homeostasis through modulation of various cellular and extracellular functions. At all levels of organization, adaptive responses are bene cial in that they enhance the capacity of all units to respond to chemical induced stress, are reversible and preserve viability. Such adaptation at subtoxic exposures is also referred to as hormesis. In contrast, adverse or toxic effects in the liver often involve chemical reaction with cellular macromolecules and produce disruption of homeostasis. Such effects diminish the capacity for response, can be nonreversible at all levels of organization, and can compromise viability. An exposure that elicits an adaptive response can produce toxicity with longer or higher exposures (ie, above a threshold) and the mechanism of action changes with the effective dose. A variety of hepatic adaptive and toxic effects has been identi ed. Examples of adaptive effects are provided by phenobarbita l and cipro brate, whereas p-dichlorobenzen e and 2-acetylamino uorene illustrate different toxic effects. The effects of chemicals in the liver are, in general, similar between experimental animals and humans, although exceptions exist. Thus, identi cation and monitoring of both types of effect are integral in the safety assessment of chemical exposures.
INTRODUCTION
The safety assessment in experimental animals of both medicinal and nonmedicinal biologically active chemicals has been very successful in predicting toxicity in humans (91) . The major advantages of preclinical safety assessment studies are the known responses of experimental species, the controlled conditions under which they can be maintained and the establishment of appropriate metrics, such as tissue volume rates, which can be applied to extrapolation of ndings in laboratory animals to assessment of possible human effects. In general, the response(s) of humans is similar to that of experimental animals, with notable exceptions, such as peroxisome proliferators (60) and a 2u globulin nephropathy inducers (105) that do not elicit in humans the same effects as in rodents.
Exposure of experimental animals to biologically effective levels of chemicals elicits a response(s) re ecting different processes by which the organizational units of an organism deal with chemical perturbation. With some types of chemical, an initial response constitutes an adaptive effect, which, if adequate, maintains homeostasis. Disruption of this equilibrium at any level of organization leads to an adverse effect, or toxicity (36, 78) . The accurate detection of both adaptive and adverse effects on macromolecules, organelles, cells, tissues, organs, and the whole organism in laboratory animals and humans is an essential component of safety assessment.
The cell is the pivotal unit in the response to chemicals. It is the central unit of organization, which together with the extracellular matrix, a modulator of many cellular functions, controls and maintains at a steady-state the internal environment of all functions/structures and the dispensing of energy in the immediate cell neighborhood and even at sites remote to a given tissue (58) . The overall balance of cellular metabolic pools has been referred to as the metabolome, which is directed by the genome via the transcriptome, whose pattern of expression of messenger RNAs for a broad spectrum of genes can be quanti ed by genomic analysis using cDNA microarrays. Likewise, the measurement of proteins constituting the metabolome or proteome is accomplished by proteomics involving 2 dimensional gel electrophoresis or arrays of protein recognition molecules. The process of maintaining homeostasis of the metabolome or proteome includes maintenance of energy metabolism, maintenance of cell and organ functions, maintenance of endocellular cytoprotective agents, regulation of protein turnover (proteasome activity), maintenance of cell size and number, and elaboration of extracellular matrix. Changes in any of these parameters constitutes a response or effect, which can be either adaptive or adverse. A complete approach to the description of these changes has been termed bionomics and the quantitative measurement of the dynamic multiparametric metabolic response of living systems to pathophysiologica l stimuli or genetic modi cation constitutes metabonomics (86) . All these methods of analysis provide re ned measures of the organismal response(s) to chemicals.
The liver is involved in the response to the majority of xenobiotics, natural and synthetic, ingested by animals or humans. It is exposed to the largest amounts of chemicals absorbed from the gastrointestinal tract via the portal circulation ( rst pass) and has the greatest biotransformation capability for the processing of chemicals (pharmacokinetic response) (94) . Also, the liver responds to many chemical actions (pharmacodynamic response) of xenobiotics. Here, we characterize chemical-induced alterations, adaptive and adverse effects, in the liver of experimental animals and consider relevance to human safety.
UNITS OF ORGANIZATION AND ACTIVITY
The cell is the central unit of biological organization. A single cell, the fertilized egg, develops into a larger multicellular organism. This occurs during embryogenesis and postnatally until germ cell maturity, through the process of proliferation followed by differentiation of pluripotential stem cells originating from the three embryonic layers. Growth during development is mainly multiplicative (increase in number of cells) or combined patterns of multiplicative, auxetic (increase in size of cells), and accretionary (increase in intercellular matrix). Around the onset of maturity, the process of differentiation becomes dominant, with selective expression in different cell types of speci c genes and gene products, which direct each cell to assume a specialized function and structure. After maturity, the processes of differentiation and proliferation are mutually exclusive, that is, a cell can either proliferate or differentiate (75) .
Maturity of an organism is attained, by conventional definition, when the germ cells are fully functional (37) . Organisms do, of course, continue to grow after maturity so de ned. Each tissue attains maturity after a duration of development speci c for the tissue and the species. The mature organism consists of 4 types of cells: static, decaying, intermediate, and renewing cells. Some mature cells, after attaining their genetically determined size and number, within the constraints of the extracellular matrix for a given organ, are not known to replicate. They are called static or permanent cells, examples of which are neurons, Sertoli cells, most striated myocytes, some cardiomyocytes, and lenticular cells. These cells can, of course, increase in size, depending on functional demand. In the second group of cells, female germ cells (ova) periodically disintegrate after differentiation over a given period, depending on the species, without replenishment, and hence, are called decaying cells. In the same group, other cells are terminally differentiated and migrate to the surface of organs and exfoliate; among these are super cial epithelial cells of all external or internal surfaces. These cells also do not replicate after they have attained their terminal differentiation. The third, and perhaps the largest group, is that of the intermediate cells such as the chondrocytes, osteocytes, smooth muscle myocytes, and some cardiomyocytes, adipocytes, brocytes, endothelia, mesothelia, and hepatocytes. These cells can replicate under certain conditions, although they do so infrequently. The fourth group consists of replicating cells that include brown adipocytes, endocrinocytes, and exocrinocytes, which replicate frequently depending on signals from the endocrine, neural, and immune systems. Some cells in this group are continuously replicating, such as the hematolymphoreticular cells, epidermocytes, ductular cells, mucosal epithelia, and urothelia. Also included in this group are thymocytes, in which, as the organism ages, the rate of apoptosis outstrips the rate of replication resulting in atrophy (or involution) of the organ. Thus, the cells of all of these groups can be divided into two broad categories; one comprised of the cell types capable of replication or renewal, and the other of cell types that are not capable of replication or renewal.
Another important element in tissue organization is the extracellular matrix, composed of structural proteins (collagens), adhesive proteins ( bronectin and laminin), matrix metalloproteinases and local growth factors, hormones, and neurotransmitters. The extracellular matrix serves as a regulator of cell polarization, secretion, proliferation, and apoptosis (36, 92) . Hormones, growth factors and neurotransmitters play an important role in directing these regulatory processes. Also, extracellular matrix-associated factors can play a role in nuclear DNA repair (36) .
Over the life span, the function and structure of organs change, due both to genetic and environmental in uences. Aging has been de ned as a series of irreversible biological and behavioral changes that reduce the ability of an organism to respond to stress (7) . Thus, mild stresses may be dealt with adequately in young organisms, whereas in older organisms, in which a different steady state obtains, the same stress may overcome compensatory mechanisms. All at the infra or supracellular unit level.
In the various cell types, quanti able alterations at the molecular unit level underlie alterations at the organelle level, which in turn lead to alterations at the cellular level, and ultimately at the systemic level. Conversely, systemic alterations such as body temperature changes can affect cell function. The mode of quanti able alterations can be quantal (binary), either all or none, as with cell replication, apoptosis, and differentiation, which are at the cellular unit level. Alterations can also be more graded or continuous (nonbinary), as with enzyme induction, organelle hypertrophy, and extracellular matrix elaboration and are either at the intra-or extra (supra) cellular unit level. Change in any cellular function or tissue structural component constitutes a response or effect. The various modes of quanti able alterations are given in Table 1 . The way the alterations occur over time is given in Table 2 . The outcome of response depends on the contribution of any or all of these parameters.
ADAPTATION AND ADVERSE EFFECTS
A chemical-induced effect is a uniform quanti able change (ie, statistically signi cant) in the function or structure of any of the units of organization. A true effect is dose-related and reproducible.
The various cell types in an organ differ in their susceptibilities to chemical effects. This is determined by effective exposure, biotransformation capability, and replication fre- 
Do not compromise viability at all levels of tissue organization
Constitute potentially bene cial effect on function or structure Result in enhanced capacity to respond to stress Are reversible quency (ie, growth fraction). Renewing cell types are highly vulnerable because of the activity of the mitotic apparatus and a limited time for DNA repair as a consequence of cell cycling. Also, renewing cells generally have less biotransformation capability, a smaller number of lysosomes and peroxisomes, low amounts of endogenous cytoprotective agents, and a high rate of lactate production. The latter feature enables the renewing cell to avoid the nonproductive hydrolysis of ATP, thus providing ample energy for replication. Furthermore, wasteful hydrolysis of ATP results in excess heat, which promotes the breaking of hydrogen bonds in both nuclear and mitochondrial DNA (13, 36, 50, 66, 76) .
The response of organisms to chemical stimuli has long been the subject of research. In pharmacology, the term progressive tolerance was introduced by Remmer (104) to describe the gradual reduction of the hypnotic effect of phenobarbital with chronic administration as a consequence of the enhancement of its biotransformation and clearance. Other investigators applied the term adaptation for this phenomenon of enhanced biotransformation (28, 32) . Adaptation may be de ned as the effect of a chemical, endogenous or exogenous, on regulatory pathways leading to modulation of cellular function or structure in a way that preserves homeostasis. For the liver, as discussed later, the adaptive effect is often mediated by receptor binding. The characteristics of adaptive effects are given in Table 3 . Adaptation encompasses the phenomenon of hormesis, which is the stimulation of biological effects at exposures below the toxicity threshold (19) .
The actions of chemicals that disrupt homeostasis, if severe or sustained, lead to adverse effects or toxicity. The typical toxic action is the reaction of a chemical or its reactive metabolite(s) with cellular macromolecules to produce covalent binding or other chemical alterations of the substrate (54) . Also, chemicals can indirectly generate other intracellular reactants, such as reactive oxygen species (12, 46, 139) . Such chemical reactions, in contrast to reversible receptor binding, lead to dysfunction and degradation of the affected macromolecule, except in the case of sublethal damage of DNA, which is subject to repair by a variety of processes. The characteristics of adverse effects are given in Table 4 . The most severe of these is cell death, which is often mediated by in ux of calcium as the cell loses its ability to maintain the gradient between intracellular and extracellular calcium levels (43) .
Among toxic effects, genomic DNA alteration is brought about in a variety of ways. These include inhibition of deamination (eg, pentostatin) and of purine biosynthesis Can be lethal at the cellular or organismal level Impair function or structure Diminish capacity to respond to stress Can be irreversible (eg, 6-mercaptopurine) or pyrimidine biosynthesis (eg, N-(phosphonacetyl-L-aspartic acid). Another is inhibition of ribonucleotide interconversions mediated by ribonucleotide reductase (eg, hydroxyurea), inhibition of thymidine monophosphate synthesis (eg, 5-uorouracil), or dihydrofolate reductase (eg, methotrexate). Other modes include direct inhibition of DNA biosynthesis (eg, cytarabine), intercalation into double-stranded DNA (eg, anthracyclines), DNA scission and fragmentation (eg, bleomycin), inhibition of DNA topoisomerases (eg, camptothecin, etoposide), and DNA adduct formation (eg, 2-acetylamino uorene). In addition, mitochondrial DNA alteration can be produced by inhibition of mitochondrial DNA (mtDNA) polymerase c or incorporation into mtDNA as with antiviral nucleoside analog drugs (eg, aluridine) (71) .
Other macromolecular disruptions include binding to RNA, inhibition of RNA biosynthesis (eg, anthracyclines), binding to proteins, or inhibition of protein biosynthesis (eg, L-asparaginase). Of importance is the fact that agents can disrupt more than 1 macromolecular unit (eg, anthracyclines). Indeed, most chemical-reactive agents interact to a greater extent with cellular protein and RNA than with DNA because of the greater abundance of these macromolecules and their proximity to intracellular sites of chemical bioactivation. Suf cient macromolecular damage of any type leads to cell death (42, 43) .
DNA is the only macromolecule that is subject to repair of alteration, which, of course, re ects the essential role of DNA in directing cellular processes. In general, humans have a higher DNA repair capacity than rodents. DNA damage elicits expression of DNA damage response genes, such as TP53, whose gene product p53 protein produces growth arrest, allowing for DNA repair. Repair of DNA damage is highly efcient and of highly accurate, thereby maintaining the integrity of the genome (72) . Mitochondrial DNA repair, in contrast, is almost nonexistent (50, 125) . Severe nuclear or mitochondrial DNA damage leads to cell death, either through necrosis or apoptosis. DNA damage stabilizes and activates p53, which leads to apoptosis mediated by other proteins such as p53regulated Apoptosis Inducing Protein 1 (p53AIP1) (89) . In the repair of nuclear DNA damage, poly (ADP-ribose) polymerase (PARP) acts together with the DNA damage repair system to regulate base excision repair (34) . With extensive damage, PARP activity depletes cellular energy pools, which may lead to cell death (34, 99) .
Cellular systems respond to toxic chemicals in a variety of ways. One is by pumping hydrophobic cationic chemicals out of the cell through drug transporters. The ATP-binding cassette (ABC) transporter family includes P-glycoprotein (for permeability) (61), the multidrug resistance proteins (MRP) and breast cancer resistance protein (BCRP) (10, 55) . Some of these systems are inducible (69) . Likewise, certain forms of DNA repair are also inducible (34, 88) .
Numerous cytotoxic chemicals elicit a stress response mediated by heat shock proteins (HSP) (87) . Some HSP are constitutive and function as molecular chaperones (108) . Others are expressed upon cellular stress and provide cytoprotection against stress-induced molecular damage. The HSPs aid in cellular repair by preventing damage caused by the accumulation and aggregation of nonnative proteins. In addition, HSPs cause structural changes such as mitochondrial shifts, increases in gene expression, chromatin condensation, bundles of laments in the nucleus, and the breakup of Golgi (75) . Although indicative of cytotoxicity, the induction of HSP can be considered adaptive.
All of the above cytotoxic stimuli can result in compensatory cellular proliferation to replace incapacitated or dead cells. Of importance in adverse effects is the time sequence of events, that is, which toxic effect occurred rst. If the DNA alteration preceded all others, then the adverse effect is direct and fundamental, compounding all other effects. Nevertheless, even then the threshold of cumulative doses must elicit the critical binary responses (Table 1 ) in order to result in irreversible adverse effects. If a DNA effect is not present, then cell death can lead to sustained regenerative cell proliferation, which in turn can lead to the development of neoplasia (18, 26) .
In general, continuous (graded or nonbinary) functional alterations, because they require less energy, adapt easier and faster compared to quantal (binary) and structural alterations (Table 1 ). Moreover, the receptor level target adapts faster than the response to macromolecular alterations, which adapt before the organelle level response, which in turn adapts before the cellular level response (Table 2 ). Furthermore, the type of cell is also very important, with renewing cells being more vulnerable to injury, because they have additional replication machinery (ie, the mitotic spindle) that can be affected. At all levels, the capacity of adaptation depends on the xenobiotic residence time and concentration (volume) for any given organ (57) .
The interplay between adaptive and adverse effects is shown in Figure 1 . An adaptive effect if sustained may lead to disruption of homeostasis and thereby exceed a threshold resulting in an adverse effect.
LIVER STRUCTURE AND FUNCTION
The liver, like other organs, undergoes programmed phases of growth and development. During embryogenesis and postnatal development until maturity, the process of proliferation is followed by differentiation (59) . Generally, humans at birth have functionally immature livers, whereas rodents and dogs are born with mature livers (96) , although hepatic hematopoiesis continues almost throughout mature life in rodents. At maturity, the process of differentiation leads to the commitment of differentiated cells, the hepatocytes, to performing the necessary housekeeping functions that maintain their homeostasis through adaptation and also to exercising their numerous specialized functions. In the rat liver, at maturity, sexual dimorphism of certain functions, notably biotransformation activity, appears such that males have greater biotransformation levels than females (37, 62, 79, 94, 96, 100) . This sex difference is modulated by gonadal hormones (64, 100) .
In all mammalian species, the liver is located in the anterior/upper right part of the abdominal cavity below the diaphragm. It is composed of the right lobe (largest in humans), the median lobe (quadrate in humans), left lobe (largest in rodents), and caudate lobe. The livers of all laboratory mammals, primates, and humans, except the rat, have a gall bladder. The hepatocellular parenchyma accounts for 60% of the total cell population and 80% of the total volume of the organ, with the lobular parenchyma representing approximately 93%, the hepatic veins 4% and the portal triads 3% of the hepatic parenchyma. Nonparenchymal cells comprise 30 to 35% of the total number of liver cells but only 6% of the total liver volume. Almost half (40%) of the nonparenchymal cells are fenestrated endothelial cells. The remainder consists of phagocytic Kupffer cells (33%), extraluminal fat-storing cells of Ito (stellate or pericytes; 22%), biliary epithelial cells (4%), pit cells (or natural killer cells; 1%), adrenergic or peptinergic nerve cells in primates and dogs, and mast cells in the dog (5, 37, 74, 79) .
Various species differ in the weight of the liver relative to body weight, the liver/body weight ratio (LBR) ( Table 5 ). In general, human LBR is 60 to 62% of the LBR of the mouse, rat or dog. In all species, females have a lower (10-20%) LBR than males, and immature animals have a higher LBR than older animals (57) .
The liver of mammals receives the portal venous blood ow from the gastrointestinal tract and about 30% of the resting arterial circulation (49, 52, 74) . Lymph ow from the liver is estimated to be 25 to 50% of the total thoracic duct ow, or approximately 0.5 ml/kg of liver/minute (11) .
Larger species have a lower metabolic rate per unit of body weight, slower rate of tissue distribution of blood-borne substances, and longer tissue residence time (39, 40, 57) . Tissue volume directly affects the volume of distribution of xenobiotics, their systemic clearance, bioavailability, and their half-life (4). Consequently, useful metrics for comparing laboratory animals and humans are the tissue/organ volume and plasma ow rate of the liver. As shown in Table 5 , the rat and dog have a longer residence time, at peak concentrations, for xenobiotics (57) . This has consequences in biotransformation, enzyme activation and organelle proliferation. Ingested xenobiotics rst enter the liver via the portal blood and are accompanied by absorbed nutrients, endogenous metabolic products, immune complexes, denatured proteins, low and high density lipoprotein particles. All of these substances are disposed through the organ depending on their hydrophilic/hydrophobic properties and delivered into either the systemic circulation, the biliary system, or the lymphatic system. Hydrophobic substances are highly cholephilic and lymphophilic. Males in general have a higher cellular membrane potential, which retards clearance through the tissue (127) .
Hepatocytes in mammals are organized in unicellular cords with 2 basolateral domains facing the sinusoidal space from which uptake of blood-borne contents takes place. Tight junctions are formed between adjacent hepatocytes and communication between hepatocytes occurs through gap junctions, which are formed by connexons in the membrane of connecting cells (74, 79) . Half of the hepatocyte volume is occupied by organelles. Unlike other cells, hepatocytes produce energy both for their own needs and for other tissues (37) . This occurs via hexokinase from carbohydrates, and phosphoenolpyruvate carboxykinase (PEPCK) which allows the production of glucose via pyruvate from amino acid metabolism. In addition, glycerol kinase (GK) in hepatocytes allows glucose production from glycerol. Insulin, glucagon, glucocorticoids, catecholamines, corticotropin, growth hormone, T 3 , T 4 , gastroinhibitory peptide, secretin, and cholecystokinin in uence hepatic glucose metabolism. Similarly, the liver produces a number of other products for systemic distribution, including protective elements such as glutathione.
Hepatocytes in all species are intermediate cells. Normally, their frequency of proliferation, that is the growth fraction, is extremely low, < 5% (15, 51) , re ecting a low rate of cell death through apoptosis (111) . Hepatocytes can replicate upon loss of functional liver mass to restore the liver to its physiologica l mass (14, 45) . Several factors involved in the regulation of cell death and proliferation of hepatocytes have been identi ed, including IGF-I, IGF-II, TNFa , NF-j B, STAT3, AP1, HGF, and uPA (81) . Interestingly, hepatocytes do not express the bcl-2 gene (103), which codes for an antiapoptotic protein.
The liver is involved in the processing of nutrients and is the principal organ for biotransformation of chemicals (38, 94, 96, 100) . Biotransformation occurs principally in the endoplasmic reticulum of hepatocytes, mediated by phase I (cytochrome P450) oxidative enzymes and phase II conjugating enzymes (94) . These activities are in uenced by gonadal hormones (21, 100) . Peroxisomes and mitochondria are also involved in some aspects of biotransformation; for example, peroxisomes become involved with highly lipophilic xenobiotics (21) .
Hepatocytes form bile canaliculi at their secretory pole from adjacent portions of their apposing cell membranes. The bile canaliculi are separated from blood by the tight junctions. Bile is secreted into the canaliculi and hence to bile ducts. Only rats possess a periportal ductular biliary plexus, which probably serves the purpose of bile storage, as this species has no gall bladder (136) .
The major organic compounds secreted into bile by hepatocytes are bile acids, phospholipids , cholesterol, bile pigments, and proteins. Bile ow in the canaliculi is an osmotically driven water ow in response to osmotic components secreted into the bile (83) . The excretion of xenobiotics, generally as conjugates, into the biliary system is mediated by ATPdependent membrane transporters including the canalicular multispeci c organic anion transporter, cMOAT or MRP2, as well as MRP3, MRP6, P-gp, and BCRP. Several of the ATP-dependent transport systems are located on the biliary canalicular side of the hepatocyte (5) . These transporters are encoded by the multidrug resistance (MDR) gene, which is a member of the ATP-binding cassette transporter superfamily (10, 55) . Most rodents have three MDR genes whereas monkeys and humans have two. P-gp is both species-speci c and strain-speci c; for example, the F344 strain has the lowest levels (63) . Several xenobiotics, including erythromycin, rifampicin, tamoxifen and profenecin, induce liver P-gp (47) , which can be considered an adaptive effect.
Within the hepatocellular lobular structure, there is zonation of gene expression and functional heterogeneity, with different gradients. For example, glucagon/insulin/ phosphoenol-pyruvat e carboxykinase activities are highest periportally and lowest centrally. In contrast, glutamine synthetase activity is con ned to the centrilobular zone such that it replenishes glutamine in blood leaving the liver (113) . A major determinant of the zonation is the O 2 gradient, with O 2 concentration of blood being highest periportally where the arterial blood enters. Thus, the zonation of the oxidative energy metabolism with glucose release, gluconeogenesis, glutathione metabolism, cholesterol synthesis, albumin, brinogen, and a 2 macroglobulin synthesis and bile formation all take place mainly in the periportal zone. Amino acid and ammonia metabolism and plasma protein formation take place in the centrolobular zone. Glucose uptake, glycolysis, liponeogenesis, glutamine formation from ammonia, xenobiotic metabolism and conjugation, angiotensinogen, a 1-antitrypsin, and a -fetoprotein formation take place centrilobularly (38, 49, 62) . In general, zonation is species, strain and gender speci c, as exempli ed by glutamine synthetase (113) .
As a consequence of their metabolic and biotransformation activities, hepatocytes are subject to various cellular stresses. They are well protected against chemical injury by high levels of cytoprotective agents, such as glutathione and high levels of anti-oxidant enzymes, including glutathione peroxidase, superoxide dismutase, heme oxygenase, anti-oxidant protein 2 (Aop2), a member of the thiol-speci c antioxidant (TSA) family of enzymes, and peroxisomal catalase (50, 102) . Moreover, hepatocytes elaborate type 2 acute phase proteins (44) that serve to maintain homeostasis and reduce tissue destruction consequent to in ammatory injury. Also, hepatocytes are well equipped with DNA repair systems (23, 88) that respond to DNA damage produced by a wide variety of chemicals, many of which are bioactivated by hepatocytes (133) . This, together with the fact that hepatocytes are nonproliferating and accordingly do not sustain much DNA damage in the vulnerable S-phase of DNA replication (117) , renders hepatocytes tolerant to levels of DNA damage that are lethal to other cell types (77) .
Among the nonparenchymal cells, the endothelial cells line the sinusoids through which blood passes from the portal triads to the central veins. These cells have fenestrae of variable size and number, which allows centrilobularly for a higher endothelial porosity, thereby creating a portal to central intralobular O 2 gradient. The Kupffer cells are mainly found periportally, where they are also of larger size. These cells are phagocytic and manufacture vasoactive mediators. The stellate (Ito) cells are located in the space of Disse, between endothelial cells and hepatocytes, mainly periportally. They have multiple roles in the pathophysiolog y of the liver, including as major storage sites of retinoids and lipophilic substances (9) . In the presence of liver injury, stellate cells manufacture collagen. The pit cells are granular lymphocytes that respond to proliferation signals from the Kupffer cells. Depletion of Kupffer cells results in loss of pit cells. Conditions of hepatocellular loss similar to partial hepatectomy activate Kupffer cells (135) .
The extracellular matrix of the liver is produced by stellate cells (74) . As with other tissues, it modulates liver function. For example, degradation of the matrix during partial hepatectomy releases matrix-bound inactive prohepatocyte growth factor, which in turn stimulates hepatocyte DNA synthesis (81) .
With aging, the human liver diminishes in size and hepatic blood ow is reduced (100, 107) . This is accompanied by reduced biotransformation capability (100) . Hepatocytes undergo change during the aging of an organism. A prominent aspect is the accumulation of lipofuchsin, resulting from lipid peroxidation and mitochondrial damage (35, 67, 76) . Although it has not yet been studied, some aging changes in the liver could be related to alteration in the expression of nuclear receptors that govern signals for gene expression.
HEPATIC ADAPTIVE AND ADVERSE EFFECTS Adaptation
For liver effects, the term adaptive has been used to denote an increase in liver size to accommodate increased functional load (28, 32, 110) . As discussed before, this can be understood as a modulation of regulatory pathways initiated by binding of a chemical ligand to a receptor. A variety of xenobiotic receptors are expressed in the liver (Table 7) . After ligand binding, the receptor complex is translocated to the nucleus, where it activates gene expression through interaction with DNA xenobiotic response elements (126) . In the case of xenobiotic binding to the Ah or CAR receptors, this results in a pleiomorphic response including induction of phase I and II enzymes that catalyze biotransformation of the inducing chemical, enhancing the ability of the liver to dispose of it. Such adaptive effects, if they do not disrupt homeostasis, do not compromise hepatocyte viability. These adaptive effects are reversible upon cessation of exposure (21, 100) . Hepatic adaptive effects are presented in Table 6 .
Hepatic adaptive effects include increased hexokinase and phosphoenolpyruvat e carboxykinase activities, induction of (Table 6 ). An unusual form of adaptation in the liver is increased hepatocellular multinucleation. These multinucleated cells are not associated with proliferative changes, but are accompanied by centrilobular hepatocellular hypertrophy, increase in transaminases, bilirubin, and cholesterol. In rats, males have displayed greater sensitivity than females to multinucleation produced by rifabutin, colchicine, thiourea, and methotrexate (109) . Adaptive effects lead to hyperplasia of organelles, mainly endoplasmic reticulum and peroxisomes, which leads to compensatory hepatocellular hypertrophy as increase in functional demand leads to organelle expansion (Figure 2) . By enhancing the capacity of the liver to respond to stress, the level of homeostasis for protein catabolism is raised (78) . One potential adaptive effect includes the heat shock proteins (HSP) (87) , which, however, have not been extensively studied in liver.
Xenobiotic effects in the liver are determined by the residence time and concentration, as with other organs. The rat and dog have a longer hepatic residence time, at peak concentrations, compared to humans (Table 5 ), making the livers of these species more vulnerable to chemical injury. Liver enlargement accompanied by induction of biotransformation enzymes has been found to be elicited by numerous xenobiotics (27, 29, 32, 48, 85, 110) , notably polycyclic aromatic hydrocarbons, barbiturates, butylated hydroxytoluene , and polychlorinated biphenyls. Such liver enlargement and increased LBR can result from both hypertrophy and hyperplasia of hepatocytes. In a report on 11 candidate pharmaceuticals, liver weight increases of 20% or greater were accompanied by histological hepatocellular hypertrophy (3), re ecting organelle increase. However, neither the magnitude of hepatomegaly nor hepatocellular hypertrophy correlated with elevation of biotransformation enzymes. In general, increase in the LBR (Table 5 ) is a reliable indicator of this adaptive effect. Increases in liver weights, especially with chronic exposure, also often re ect increased cell proliferation (2, 22) .
The converse, a decrease in relative liver weight, does not accurately re ect the magnitude of reduction in body weight for both rats and mice, as observed in diet restriction studies (1, 53) .
With high exposure, an adaptive effect can become adverse ( Figure 1 ). For example, enzyme induction in the liver can lead to alterations in the metabolism of hormones (138) and in the case of phenobarbital, induction of conjugation of thyroid hormones leads to increased TSH production and ultimately to development of thyroid tumors (20) . Also, with sustained exposure, adverse effects can develop, notably reected in a sustained increase in hepatocellular proliferation and/or reduction in apoptosis. Such chronic increases in cell proliferation can lead to development of hepatocellular neoplasms (18, 26) .
The adaptive effects of 2 archetypical agents operating through different receptors are detailed.
Phenobarbital (PB): PB is typical of agents that produce hepatomegaly and induction of hepatic enzymes (80) . Evidence is accruing that PB elicits its effects on CYP2B via interaction with the constitutive androstane receptor (CAR) (126) leading to enhanced transcription of CYP2B messenger RNA. Whether the pleiomorphic effects of PB, re ecting altered regulation of about 30 genes, also are mediated by CAR binding is not yet established.
The enhancement of biotransformation by PB is usually bene cial in facilitating clearance of the inducing agent, and hence, the phenomenon of progressive tolerance (104) . In the case of liver carcinogenesis, when present before or during carcinogen exposure, enhanced detoxi cation results in diminished effects of the carcinogen (29, 97) . Conversely, when PB is administered after a hepatocarcinogen, a tumor promoting effect occurs (97) , often attributed to the enzyme induction, although no mechanistic basis for this has been established (128) . In fact, the role of enzyme induction in tumor promotion is not supported by several observations. For example, PB is an enzyme inducer in hamster liver (93), but not a tumor promoter (114) . Alternatively, PB promotion was suggested by this laboratory to be due to its inhibition of gap junctional intercellular communication (GJIC) (129, 130) , which is important in regulating cell-cell interactions (119) . Much data support the role of this cellular effect in promotion (17, 68, 119, 137) . The importance of GJIC in PB promotion is evidenced by the lack of promotion of PB in mice null for connexin 32, a component of gap junctions, although PB induced cytochrome P450 enzyme levels (82) . The inhibition of GJIC could be the basis for the stimulation of hepatocellular proliferation by PB. GJIC is involved in regulation of cell growth (73) and thus, inhibition may allow preneoplastic cells to escape growth control, and could underlie the liver tumor promoting activity and liver tumorigenicity of PB (130) . Increased cell proliferation with PB administration has been observed with as little as about a 20% increase in relative liver weight (22) . Thus, the adaptive effect of PB if moderate and transitory is not adverse, but if severe and sustained, leads to adverse effects.
However, in spite of the fact that PB is used in human medicine at dosages greater than the hepatocarcinogenic exposures in rodents, no increase in liver cancer has been found (90) . This may re ect species differences in susceptibility to promoting and carcinogenic effects (116) .
Cipro brate: Another class of xenobiotic that elicits adaptive effects in the liver of mice and rats is the class of peroxisome proliferators (24) , which bind to the a type PPAR ( Table 7) . This laboratory has conducted a dose-response study of the peroxisome proliferator cipro brate in 2 strains of mice (16) . No increase in LBR was found at up to 5 ppm, whereas increases of about 30% or more were observed beginning at 12.5 ppm, and with this exposure and greater, induction of peroxisomal enzymes was evident, being greater in the C57BL/6N mice than in the BALB/c. At the highest exposure of 250 ppm, the LBR was increased by 220% in BALB/c mice and by 180% in C57BL/6N mice. Corresponding to these strain differences in hepatomegaly, BALB/c mice exhibited greater increases in mitogenesis at 3 weeks. Similarly, in SD rats, a correlation between hepatomegaly, peroxisome proliferation and stimulation of cell proliferation has been reported for several peroxisome proliferators (2) . Thus, the PPAR-mediated response to cipro brate exhibited a threshold between 5 and 12.5 ppm and was modest at low doses. When sustained, the response led to the adverse effect of cell proliferation, which is believed to be related to the hepatocarcinogenicity of peroxisome proliferators (101) .
Peroxisome and cell proliferation increase have not been found in the livers of humans given therapeutic doses of hypolipidemic agents that are rodent peroxisome proliferators (134) or in isolated human hepatocytes (98) , apparently because the PPARa is not expressed in human liver to the same extent as in rodents and contains sequence differences that affect ligand binding (120) . Thus, humans are not considered to be at risk for the hepatocarcinogenic effects of rodent peroxisome proliferators (60).
Toxicity
As described before, hepatocytes are protected against chemical injury by a variety of molecular and enzymatic entities. Nevertheless, with suf cient chemical exposure, various processes of macromolecular disruption occur in the liver, leading to loss of homeostasis and toxicity (Figure 1 ). Toxic effects are presented in Table 8 . As discussed previously, toxic effects often result from reactions with macromolecules; a classic example is acetaminophen hepatotoxicity at high exposures due to formation of a quinone imine which reacts with and depletes glutathione at which point protein binding occurs (25) . Also, chemicals can produce oxidative stress in the liver, as with pentachlorophenol (121) . In addition to the primary molecular damage, other factors exacerbate hepatic injury including proin ammatory cytokines (8) . Also, macrophages and endothelial cells contribute to the injury of hepatocytes by the release of reactive oxygen intermediates and cytokines (6, 70) . The types of hepatic injury or impairment produced by chemical interactions involve both function and structure, as well as a diminished capacity to respond to stress. Many of these toxic effects result from macromolecular damage, which is irreversible, except for DNA alteration, up to a point. Macromolecular injury is tolerable below a threshold at which hepatocellular death, a quantal event, ensues (42) . The liver has a substantial reserve and can sustain function up to about 70% loss of hepatocellular function, beyond which systemic toxicity evolves (79, 100) . With sustainable levels of hepatocellular injury, compensatory proliferation occurs.
An increase in the LBR without an increase in biotransformation activity often indicates hepatic toxicity (33) . Increased intracellular activation by a xenobiotic can enhance and/or potentiate cytotoxicity (102) . The activation involves acetylation, hydration, demethylation, hydrolysis, microsomal oxidation/reduction, phosphorylation , phosphoribosylation, and polyglutamylation. In stress and injury, the adaptive mechanisms do not function properly because there is the creation of a hypermetabolic state in order to increase the needed energy, resulting in hyperglycemia, which triggers hyperinsulinemia, and increased urea production and nitrogen excretion. The hepatocytes have some advantages over other cell types, because they have exible energy reserves, and sarcoplasmic proteins (instead of myo brillar), enabling insulin to suppress proteolysis more effectively (78) .
Hepatocellular injury can progress to either apoptosis or necrosis (95) . Hepatocellular toxicity is often manifested by release into the blood of liver enzymes such as alanine aminotransferase, aspartase aminotransferase, lactic dehydrogenase and c -glutamyltransferase (56) as integrity of the hepatocellular cell membrane diminishes. Also induction of type 2 acute phase proteins is indicative of hepatocellular injury (118) .
Adverse quantal alterations are more deleterious, especially if they precede continuous alterations (Tables 1 and  2 ). The main reason is that binary alterations need more energy and time to repair (57) . If the continuous alterations precede, even if they are followed by quantal alterations, then the outcome is not so deleterious. When the intensity, reactivity and interval of exposure are high, and the renewing type of cell is affected, then the outcome becomes again deleterious.
Two examples of different types of hepatotoxicants are discussed.
p-Dichlorobenzene (pDCB)
: pDCB is best known as an a 2u globulin-nephropathy-inducin g chemical, which produced kidney tumors in male rats (105) . In addition, it produces hepatic effects and in chronic bioassays, induced liver tumors at high doses in mice, but not in rats (84) . In a study of the basis for the liver carcinogenicity of pDCB in mice, it produced an increase in the LBR (122) . Increased hepatocellular proliferation was found in rat and mouse liver at 1 week, whereas at 4 weeks, only the dose in mice associated with liver tumors produced increased proliferation (122) . In rats, an increased LBR of 1.3-fold was present at a dose that did not increase cell proliferation at 4 weeks, yet in the mouse at about the same increase, cell proliferation was increased (122) . The basis for the increased cell proliferation may be cyto-toxicity, because pDCB was toxic to centrilobular glutamine synthetase-expressing cells in the mouse, but not in the rat.
pDCB has not been implicated in human cancer, which may re ect species differences and a threshold for its effects.
2-Acetylamino uorene (AAF):
AAF is a DNA-reactive aromatic amine, which produces mainly liver tumors, particularly in the rat (124) . With high exposures, it also produces hepatotoxicity, which can lead to oval cell proliferation (41, 112) . AAF also can elicit some liver adaptive effects such as induction of P-gp (65) and DNA repair systems (88) . AAF is one of those hepatocarcinogens whose effects are diminished by pretreatment with enzyme inducers (97) . This laboratory has been conducting studies of the dose-response of a variety of hepatocellular effects of AAF in male F344 rats (123, 131, 132) , which are highly susceptible to AAF hepatocarcinogenicity (124) . The exposures studied ranged from those producing toxicity and promotable neoplastic initiation ( > 395 mg/kg cumulative exposure) to those producing minimal effects and no measurable initiation (40 mg/kg cumulative exposure); the latter exposure is more than 10 times lower than those exposures previously studied by others. In this study (132) , at 4 weeks, at the low dose with a cumulative exposure of 13 mg/kg, increases were found in LBR and DNA adduct formation, which persisted for 4 additional weeks with a cumulative exposure of 26 mg/kg. By week 12, with a cumulative exposure of 40 mg/kg, the LBR remained increased and the magnitude of DNA adduct formation was 29% of that of the high cumulative exposure of 395 mg/kg, at which formation of adducts had plateaued. At the low exposure, in spite of adduct formation, no promotable neoplastic initiation was manifested after administration of 500 ppm PB in the diet for 24 weeks. At the next cumulative exposure level (43 mg/kg at 4 weeks, 87 mg/kg at 8 weeks, and 130 mg/kg at 12 weeks), the liver changes, that is, LBR and DNA adduct formation, were very similar in magnitude to the lower exposures up to week 12. DNA adduct formation was greater, achieving 91% of that of the magnitude of the high exposure, and arylsulfotransferase activity, the nal enzymatic step in AAF bioactivation (106) , was inhibited and the centrilobular glutamine synthetase expressing zone was reduced, indicating cytotoxicity. This exposure produced a low level of promotable initiation (one adenoma). Finally, at the highest cumulative exposure level (132 mg/kg at 4 weeks, 263 mg/kg at 8 weeks, and 395 mg/kg at 12 weeks), all the described liver changes were produced to a substantial degree. In addition, the hepatocellular replicating fraction was increased, indicating increase in the rate of compensatory proliferation, and preneoplastic hepatocellular altered foci (HAF) were strongly induced. Under these conditions, the incidence of adenomas without promotion was 50% and with promotion, the incidence of liver tumors was 100%. Thus, only at 130 mg/kg and above of cumulative exposure, with induction of proliferation and hepatocellular preneoplastic foci, did promotable neoplasia occur. The enhanced susceptibility of proliferating hepatocytes to genotoxic agents was rst demonstrated by Craddock (31) and has been shown for a number of carcinogens (115) . Thus, enhanced proliferation was a crucial event, which, like other monitored changes, except DNA adducts, exhibited a threshold.
Humans are not exposed to AAF, but there are environmental exposures to other aromatic and heterocyclic amines with similar properties. Our ndings suggest the possibility of thresholds at very low exposures.
DISCUSSION AND CONCLUSIONS
In order to illustrate in detail the difference between hepatic adaptive and toxic (adverse) effects, several chemicals with well studied effects in the liver were reviewed. The effects detailed were at various levels of organization, such as functional enzymes, biotransformation enzymes, hepatocellular injury, hepatocellular proliferation, and development of preneoplasia and neoplasia.
At all levels of organization in the liver, adaptive responses maintain homeostasis, are reversible and preserve viability. In contrast, adverse effects disrupt homeostasis, diminish the capacity for response, are nonreversible and compromise viability. An exposure that elicits an adaptive response can produce toxicity with longer or higher exposures and the mechanism of toxicity changes with effective dose, as described by Counts and Goodman (30) . Moreover, each of these effects has well-de ned thresholds that can be established. Both adaptive and toxic hepatic effects are generally similar between experimental animals and humans, with notable exceptions such as rodent liver peroxisome proliferators. Thus, identi cation, monitoring, and principles of extrapolation of both types of effects is crucial in the safety assessment of chemical exposures.
Nonbinary functional alterations adapt more easily, even if the intensity, reactivity, and prolonged exposure interval of the stimulus poses a signi cant insult. Moreover, altered circulation can further enhance the concentration of the xenobiotic and thus narrow the range of adaptation. However, adverse quantal alterations constitute strong adverse effects, especially if they are followed by nonbinary alterations (Tables 1 and 2 ). Here the cumulative threshold, which induces these binary alterations, has to overwhelm adaptation in order to result in frank adverse effects.
Presently, from the paradigms presented, we have shown that adaptive and adverse effects in the liver can be distinguished. The adaptive nonbinary effects may not be deleterious unless they can lead to quantal alterations of sustained increases in cell proliferation, decreases in apoptosis or changes in cell differentiation. Sustained increases in cell proliferation alone or in combination with decreases in apoptosis and changes in cell differentiation lead to neoplasia and enhance susceptibility to carcinogens.
The described and discussed adaptive and adverse effects in the liver, when assessed according to appropriate parameters of interspecies extrapolation, such as the metabolic and organ volume data, constitute a basis for the assessment of relevance to humans of effects in experimental animals.
